nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2006-10-4-93-97nefr-706Research ArticleЖУРНАЛ В ЖУРНАЛЕ. АКТУАЛЬНЫЕ ПРОБЛЕМЫ УРОЛОГИИJOURNAL IN THE JOURNAL. ACTUAL PROBLEMS OF UROLOGYОЦЕНКА КАЧЕСТВА ЖИЗНИ У БОЛЬНЫХ С ГИПЕРАКТИВНОСТЬЮ МОЧЕВОГО ПУЗЫРЯASSESSMENT OF THE QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDERКузьминИ. В.KuzminI. V.

кафедра урологии

Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation2006100420061049397Copyright © Кузьмин И.В., 20062006Кузьмин И.В.Kuzmin I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/706

ЦЕЛЬ ИССЛЕДОВАНИЯ. Изучить влияние гиперактивности мочевого пузыря на качество жизни больных. ПАЦИЕНТЫ И МЕТОДЫ. Проведен анализ анкет качества жизни KHQ у 349 больных с гиперактивностью мочевого пузыря и исследовано влияние выраженности симптомов заболевания и результатов уродинамических исследований на отдельные составляющие качества жизни пациентов. РЕЗУЛЬТАТЫ. У больных с гиперактивностью мочевого пузыря происходит существенное снижение качества жизни, проявляющееся в ухудшении всех ее составляющих – социальной, семейной, эмоциональной и профессиональной. Степень снижения качества жизни зависит от выраженности симптоматики гиперактивности мочевого пузыря и различна в зависимости от пола и возраста больных. Наибольшее влияние на показатели качества жизни оказывали учащение мочеиспускания и наличие императивных позывов на мочеиспускание. Связь между степенью ухудшения качества жизни больных и результатами уродинамических исследований не выявлена. ЗАКЛЮЧЕНИЕ. Степень ухудшения качества жизни больных с гиперактивностью мочевого пузыря зависит от выраженности симптоматики, а также пола и возраста пациентов.

THE AIM of the investigation was to study the influence of overactive bladder on the quality of life of patients. PATIENTS AND METHODS. Using an analysis of questionnaires of quality of life KNQ in 349 patients with overactive bladder, the investigation concerned the degree of symptoms of the disease and the results of urodynamic examinations on certain components of the quality of life of the patients. RESULTS. Patients with overactive bladder have substantially worse quality of life, influencing the worsening of all its components – social, familial, emotional and professional. The degree of the worsening depends on the intensity of the symptoms of overactive bladder and is different in different age and gender. The greatest influence on the quality of life had more frequent urinations and imperative urges to urinate. No relationship was found between worsening quality of life and results of urodynamic investigation. CONCLUSION. The degree of worsening quality of life of patients with overactive bladder depends on the intensity of the symptoms and age and gender of the patients.

гиперактивность мочевого пузырякачество жизнианкета KHQургентное недержание мочиoveractive bladderquality of lifequestionnaire KHQurgent incontinenceReferencesAbrams P, Cardozo L, Fall M et al. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society. Urology 2003; 61 (1): 37–49Abrams P, Cardozo L, Fall M et al. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society. Urology 2003; 61 (1): 37–49Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87 (9): 760–766Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87 (9): 760–766Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2006; 175 (3): 5-10Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2006; 175 (3): 5-10Jackson S. The patient with an overactive bladder – symptoms and quality of life issues. Urology 1997; 57 (6A): 18-22Jackson S. The patient with an overactive bladder – symptoms and quality of life issues. Urology 1997; 57 (6A): 18-22Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care 2000; 6: 580-590Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care 2000; 6: 580-590Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Acta Obstet Gynecol Scand 1997; 76: 74-80Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Acta Obstet Gynecol Scand 1997; 76: 74-80Wyman JF, Fantl JA, McClish DK et al. Quality of life following bladder training in older women with urinary incontinence. Int Urogynecol J 1997; 8: 223-229Wyman JF, Fantl JA, McClish DK et al. Quality of life following bladder training in older women with urinary incontinence. Int Urogynecol J 1997; 8: 223-229O’Connor RM, Johannesson M, Hass SL, Kobelt-Nguyen G. Urge incontinence: quality of life and patient’s valuation of symptom reduction. Pharmacoeconomics 1998; 14: 531-539O’Connor RM, Johannesson M, Hass SL, Kobelt-Nguyen G. Urge incontinence: quality of life and patient’s valuation of symptom reduction. Pharmacoeconomics 1998; 14: 531-539Bushnell DM, Martin ML, Summers KH et al. Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res 2005; 14 (8): 1901-1913Bushnell DM, Martin ML, Summers KH et al. Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res 2005; 14 (8): 1901-1913Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 1997; 50 (6A): 100-107Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 1997; 50 (6A): 100-107Papanicolaou S, Hunskaar S, Lose G, Sykes D. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK. BJU Int 2005; 96 (6): 831-838Papanicolaou S, Hunskaar S, Lose G, Sykes D. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK. BJU Int 2005; 96 (6): 831-838Kobelt G, Kirchberger I, Malone-Lee J. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1999; 83 (6): 583-590Kobelt G, Kirchberger I, Malone-Lee J. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1999; 83 (6): 583-590Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21 (3): 261-274Schafer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21 (3): 261-274Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997; 104 (9): 1374-1379Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997; 104 (9): 1374-1379Donovan JL, Badia X, Corcos J et al. Symptom and Quality of life assessment. In: Incontinence: 2 nd International Consultation on Incontinence. Ed. Abrams P, Cardozo L, Khoury S, Wein A. Plymouth, 2002; 267-316Donovan JL, Badia X, Corcos J et al. Symptom and Quality of life assessment. In: Incontinence: 2 nd International Consultation on Incontinence. Ed. Abrams P, Cardozo L, Khoury S, Wein A. Plymouth, 2002; 267-316Rajkumar GN, Small DR, Mustafa AW, Conn GA. prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2005; 96 (6): 848-852Rajkumar GN, Small DR, Mustafa AW, Conn GA. prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2005; 96 (6): 848-852Kalsi V, Apostolidis A, Popat R et al. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006; 49 (3): 528-535Kalsi V, Apostolidis A, Popat R et al. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006; 49 (3): 528-535

The authors declare that there are no conflicts of interest present.